item management s discussion and analysis of financial condition and results of operations the following is a discussion of the financial condition and results of operations of the company for the three years ended december  it should be read in conjunction with the company s consolidated financial statements  the related notes thereto and other financial and operating information included in this form k 
overview integramed america  inc the company offers products and services to patients  providers  payors and pharmaceutical manufacturers in the fertility industry 
the integramed network is comprised of twenty two fertility centers in major markets across the united states  a pharmaceutical subsidiary  a financing subsidiary  the council of physicians and scientists  and a leading fertility portal www 
integramed 
com 
seventeen fertility centers have access to the company s fertilitydirect program 
five of the fertility centers are designated as reproductive science centers r and as such  have access to the company s fertilitydirect program in addition to being provided with a full range of services including i administrative services  including accounting and finance  human resource functions  and purchasing of supplies and equipment  ii access to capital  iii marketing and sales  iv integrated information systems  v assistance in identifying best clinical practices  and vi laboratory services collectively  business services 
the company s strategy is to align information  technology and finance for the benefit of fertility patients  providers  payors and pharmaceutical manufacturers 
the primary elements of the company s strategy include i selling additional fertilitydirect contracts to leading fertility centers in major markets  ii selling shared risk refund treatment packages to patients of contracted fertility centers and managing the risk associated with the programs  iii selling additional reproductive science center business service contracts  iv increasing revenues at reproductive science centers  v increasing sales of pharmaceutical products and services  vi expanding clinical research opportunities  and vii establishing internet based access to patient specific information on treatment process and outcomes 
during the first quarter of  the company completed an equity private placement of million with morgan stanley venture partners affiliates 
subsequent to  the company reacquired morgan stanley venture partners shares see note to the consolidated financial statements 
in september  the company obtained from fleet bank  na a million credit facility to fund acquisitions to provide working capital and to refinance its existing bank debt 
during  the company recorded restructuring and other charges of approximately million associated with its termination of its agreement with the reproductive science center of greater philadelphia  a single physician reproductive science center  effective july   and exclusive right impairment losses related to two other single physician reproductive science centers 
in addition  due to continued operating losses and the company s decision to focus exclusively on fertility services  the company sold the adult women s medical division awm division operations effective september  in  the company recorded an aggregate charge of approximately million related to the operating losses and the disposal of the awm division 
during  the company accelerated amortization of the right to manage fees for the kansas city and dallas reproductive science centers 
in december  the company s agreement with the medical center based reproductive science center was terminated early 
the company received million in liquidated damages pursuant to an early termination agreement 
the medical practices served by the company are parties to managed care contracts 
approximately and of the company s revenues  net for the years ended december  and  respectively  were derived from revenues received by the medical practices from third party payors 
to date  the company has not been negatively impacted by existing trends related to managed care contracts 
as the company s fees for servicing such medical practices are based on revenues and or earnings of the respective medical practices  changes in managed care practices  including changes in covered procedures or reimbursement rates could adversely affect the company s fees in the future 
the company is under pressure to reduce fees to the medical practices and may be forced to reduce its fees 
cost containment measures may not be enough to offset these fee reductions 
in addition  as the company implements its change in strategy to become more of a marketing oriented rather than a service based company  costs of implementation may be incurred prior to achieving the related revenues 
as a result of these two issues  future income levels may be reduced and the company may not achieve the earnings level experienced in results of operations the following table shows the percentage of net revenue represented by various expenses and other income items reflected in the company s consolidated statement of operations for the years ended december   and revenues  net costs of services incurred employee compensation and related expenses direct materials occupancy costs depreciation other expenses total costs of services incurred contribution general and administrative expenses amortization of intangible assets interest income interest expense total other expenses restructuring and other charges income from continuing operations before income taxes provision for income taxes income loss from continuing operations a discontinued operations loss net income loss a excluding the effect of the restructuring and other charges in  income from continuing operations  as a percentage of net revenues would have been for the year ended december  calendar year compared to calendar year revenues  net for were approximately million as compared to approximately million for  an increase of million or 
the increase in revenues was approximately attributable to new pharmaceutical sales started during the second quarter of and attributable to same market growth offset by losses of revenue due to terminated or modified business services contracts 
same market growth was principally achieved via new service offerings  the expansion of ancillary services  and increases in patient volume 
the aggregate increase in revenue was comprised of the following i an approximate million increase in reimbursed costs of services  ii an approximate  decrease in the company s business services fees derived from the managed medical practices net revenue and or earnings  iii an approximate million decrease from terminated business service agreements and iv an increase of million from pharmaceutical sales 
total costs of services as a percentage of revenue increased by to in as compared to in the primary contributor to this increase was the million increase in the costs of pharmaceutical materials as the cost of these materials represents a higher proportion of the revenue dollar than the business services costs 
contribution decreased to million in as compared to million in due to the factors attributed to increasing costs of services 
the contribution margin decreased to of revenues in from in primarily due to pharmaceutical sales accounting for a higher percent of revenues and providing lower margins 
general and administrative expenses for were approximately million as compared to approximately million in  a decrease of 
this decrease was primarily due to decreases in staffing  legal expenses  and expenses related to the implementation of information systems 
amortization of intangible assets was  in as compared to million in the majority of this decrease is attributed to a one time charge incurred in of million associated with accelerated amortization of the right to manage fees of the kansas city and dallas reproductive science centers 
interest income for increased to  from  for  due to a higher invested cash balance 
interest expense for increased to  from  in  primarily due to capitalized leases and the rising level of market interest rates 
the provision for income taxes is primarily related to state taxes as the company has utilized available net operating loss carryforwards to eliminate any federal tax provision 
the provision for income taxes decreased for the year ending december  as compared to  due to a change in effective tax rates as a result of tax planning initiatives 
income from continuing operations was approximately million in as compared to  for the increase was primarily due to i an approximate  decrease in general and administrative expenses  offset by a decrease of  in contribution  ii an approximate million decrease in amortization of intangible assets  and iii and a  reduction in net interest expense 
calendar year compared to calendar year revenues  net for were approximately million as compared to approximately million for  an increase of million or 
the increase in revenues was approximately attributable to new business services agreements entered into during the second quarter of and attributable to same market growth offset by losses of revenue due to terminated business services contracts 
same market growth was principally achieved via new service offerings  the expansion of ancillary services  and increases in patient volume 
the aggregate increase in revenue was comprised of the following i an approximate million increase in reimbursed costs of services  and ii an approximate  increase in the company s business services fees derived from the managed medical practices net revenue and or earnings  and iii million from pharmaceutical sales 
total costs of services as a percentage of revenue increased by to in as compared to in employee compensation and related expenses  direct materials  depreciation and other expenses increased primarily due to factors attributed to increasing revenues 
these factors include infrastructure expansion for various reproductive science centers  including shady grove  bay area  and boston 
contribution increased to million in as compared to million in due to the factors attributed to increasing revenues 
the contribution margin decreased to of revenues in from in primarily due to reimbursed services  which do not provide a margin  accounting for a higher percent of revenues and new service offerings with a lower contribution margin 
general and administrative expenses for were approximately million as compared to approximately million in  an increase of  primarily due to increases in staffing  legal expenses  and expenses related to the implementation of the artworks system 
amortization of intangible assets was million in as compared to million in the majority of this increase is attributed to a one time charge of million associated with accelerated amortization of right to manage fees of the kansas city and dallas reproductive science centers 
interest income for decreased to  from  for  due to a lower invested cash balance 
interest expense for decreased to  from  in  primarily due to payoffs of notes payable to the physician practice at shady grove 
the provision for income taxes is primarily related to state taxes as the company has utilized available net operating loss carryforwards to eliminate any federal tax provision 
the provision for income taxes decreased for the year ending december  as compared to  due to a change in effective tax rates as a result of tax planning initiatives 
income from continuing operations  excluding restructuring and other charges  was approximately  in as compared to million for the decrease was primarily due to the approximate  increase in contribution and a  reduction in income tax expense  which was offset by an  increase in general and administrative expenses and a million increase in amortization of intangible assets 
liquidity and capital resources historically  the company has financed its operations primarily through cashflow  sales of equity securities and bank financings 
as of december   the company had working capital of approximately million  compared to million in the net decrease in working capital was primarily due to debt repayments of million and the repurchase of approximately  shares of common stock for an aggregate purchase price of million 
in september  the company obtained from fleet bank  na fleet a million credit facility the new credit facility 
the new credit facility is comprised of a million three year working capital revolver  a million three year acquisition revolver and a million year term loan 
upon closing of the new credit facility  the company drew the entire million available under the term loan to repay in full its balance outstanding with first union national bank of  and for working capital purposes as well as common stock repurchases 
availability of borrowings under the working capital revolver are based on eligible accounts receivable as defined 
availability of borrowings under the acquisition revolver will be based on financial covenants and eligibility criteria with respect to each proposed acquisition 
as of december   under the working capital and acquisition revolvers  there were no amounts outstanding and an aggregate amount of approximately million was available 
the company does not have any significant commitments for the acquisition of fixed assets 
new accounting standards pursuant to the securities and exchange commission s staff accounting bulletin sab  revenue recognition in financial statements  the company has reviewed its accounting policy for the recognition of revenue 
sab no 
was required to be implemented in fourth quarter sab no 
provides guidance on applying generally accepted accounting principles to revenue recognition in financial statements 
the company s policy for revenue recognition is consistent with the views expressed within sab no 
forward looking statements this form k and discussions and or announcements made by or on behalf of the company  contain certain forward looking statements regarding events and or anticipated results within the meaning of the safe harbor provisions of the private securities litigation reform act of  the attainment of which involve various risks and uncertainties 
forward looking statements may be identified by the use of forward looking terminology such as  may  will  expect  believe  estimate  anticipate  continue  or similar terms  variations of those terms or the negative of those terms 
the company s actual results may differ materially from those described in these forward looking statements due to the following factors the company s ability to acquire additional business services agreements  including the company s ability to raise additional debt and or equity capital to finance future growth  the loss of significant business services agreement s  the profitability or lack thereof at reproductive science centers serviced by the company  increases in overhead due to expansion  the exclusion of fertility and art services from insurance coverage  government laws and regulation regarding health care  changes in managed care contracting  the timely development of and acceptance of new fertility  and art and or genetic technologies and techniques 
item a 
quantitative and qualitative disclosures about market risk not applicable 

